Researchers at IDIBELL and IMB-CNM have developed a new vascularized cardiac model—a chip integrated with living cardiac tissue generated from human stem cells—that could advance our understanding of cardiotoxicity, one of the main barriers currently facing drug development. The new model is emerging as an alternative to reduce the use of animal models and prevent the discarding of promising drugs due to an overestimation of their cardiac toxicity

Microdevices with piezoelectric nanostructures developed by the IMB-CNM and the UAB enable remote, effective, and controlled stimulation of cells. Activated by biomedical ultrasound, these microdevices generate electrical signals capable of inducing cellular responses, thereby opening new avenues for the development of less invasive and more precise therapies

A study led by the Institute of Microelectronics of Barcelona (IMB-CNM-CSIC) and the Catalan Institute of Nanoscience and Nanotechnology (ICN2) has developed a neural interface that brings together two graphene-based technologies in a single device, with the potential to improve current approaches to modulating brain activity. Successfully tested in mouse models, this advance could be key to developing future therapies for conditions such as epilepsy and brain damage

The publication covers the CSIC's different strategies for advancing qubit-based technology, in which the IMB-CNM highlights three different approaches

Unlike other systems, this device is made of two materials that react oppositely when in contact with each vapor. The response, visible as a change in color pattern, allows the detection of everything from alcohols to solvents present in the environment or in household products

Developed at the CSIC's Institute of Microelectronics of Barcelona, they have been successfully tested in standard LINAC radiotherapy accelerators. They offer promising capabilities for many applications, such as neutron dosimetry, radiation monitoring, nuclear safety, and scientific research

A study led by IMB-CNM presents extremely miniaturized piezoelectric microdevices capable of generating electrical signals without the need for wires or batteries, with the aim of stimulating individual cells. This is an advance towards the future of wireless, minimally invasive, and personalized medical therapies

The system, designed and manufactured by IMB-CNM-CSIC, is more resistant and economical than conventional dosimeters for measuring doses that could be administered in the new advanced radiotherapy modality called FLASH, which is still under development. Its efficiency has already been tested in basic research particle accelerators